Prothena Corporation plc (PRTA) Financials

PRTA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 302.6 million 15.7 million
March 31, 2026 349.9 million 37.3 million
Dec. 31, 2025 326.8 million 46.3 million
Sept. 30, 2025 352.6 million 57.6 million

PRTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -25.7 million 7.9 million
March 31, 2026 28.9 million 6.9 million
Dec. 31, 2025 -23.3 million 7.1 million
Sept. 30, 2025 -40.6 million 7.2 million

PRTA Net Income

No data available :(

PRTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 288.2 million - 4.0 million
March 31, 2026 329.5 million 4.8 million 2.9 million
Dec. 31, 2025 307.5 million 5.5 million 5.5 million
Sept. 30, 2025 330.8 million - 9.1 million

PRTA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 52.1 million
March 31, 2026 54.1 million
Dec. 31, 2025 53.8 million
Sept. 30, 2025 53.8 million

PRTA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 652000 8.8 million 10.9 million -
March 31, 2026 - 12.6 million 12.7 million -
Dec. 31, 2025 2040 14.6 million 12.6 million -
Sept. 30, 2025 10000 28.9 million 13.2 million -

PRTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.0 million -
March 31, 2026 51.1 million 918000
Dec. 31, 2025 21000 942000
Sept. 30, 2025 2.4 million 28.9 million

PRTA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PRTA

Price: $8.35

52 week price:
7.73
11.80

Earnings Per Share: -0.82 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Ireland

Volume: 314000

Ebitda: -47.3 million

Market Capitalization: 424.0 million

Links: